Systemic Anti Cancer Therapy (SACT) Patient Information leaflets.
If you cannot find the leaflet you require, please contact our patient information manager Leigh Porter for assistance.
General Chemotherapy
Macmillan
Cancer Research UK
- EcarboF 377
- EcarboX 374
- ECF 4
- ECF 362
- EC-T
- ECX 277
- Encorafenib and Binimetinib
- Encorafenib and Cetuximab A1294
- (Enhertu®) Trastuzumab deruxtecan
- Entrectinib A1254
- Enzalutamide 690
- Epirubicin, Carboplatin, Paclitaxel, Cyclophosphamide and Pembrolizumab 547, A1023, A1600 and A1162
- Epirubicin, Cyclophosphamide and Paclitaxel A1023, A1601, A1228, A1229
- Erlotinib (Tarceva) 449
- Eribulin 647
- Etoposide 338
- Etoposide, Doxorubicin and Cisplatin chemotherapy 670
- EOX 276
- Everolimus 484
- Extravasation
- Paclitaxel 402,242 & 662
- Palbociclib 949
- Panitumumab with oxaliplatin, 5 fluorouracil and folinic acid (OxMdG) A1047
- Pembrolizumab and Lenvatinib A1553
- Pemetrexed
- Phesgo
- Pixantrone
- Pazopanib
- Pemetrexed and carboplatin 570
- Pembrolizumab 836
- Pembrolizumab, Paclitaxel, Carboplatin, Epirubicin and Cyclophosphamide, 547, A1023, A1600, A1162
- Pemetrexed and cisplatin 354
- Princess of Wales
- Procarbazine, lomustine and vincristine 95 (PCV)
- PICC line - Securacath